Tony, my "Hunch" is ZIVO seems to be done with tests and new experiments and now focused on cutting a deal or selling the company. They are not staffed to continue on or in a position to raising more cash without massive dilution. So MY logical conclusion is they cut a deal with a large animal pharma or a large company that deals in algae strains of which ZIVO has proprietary patents etc.
**OPTIONS AS I SEE IT** Sell the whole company Sell a portion of the company License a portion of the company
Market Data 
Markets 
AI
